NCT06159335View on ClinicalTrials.gov

18F-FLUC PET/MR in Patients With Brain Mets

PHASE3RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Brain MetastasisRadiation TherapyImmunotherapy, Active

Interventions

RADIATION

F-Fluciclovine radiotracer

Participants will receive PET radiotracer and MRI

Trial Locations (1)

53705

RECRUITING

University of Wisconsin, Madison

Sponsors

Collaborators (1)

Blue Earth Diagnostics

All Listed Sponsors

collaborator

Blue Earth Diagnostics

INDUSTRY

lead

University of Wisconsin, Madison

OTHER

NCT06159335 - 18F-FLUC PET/MR in Patients With Brain Mets | Biotech Hunter | Biotech Hunter